CRL reports Wednesday, Nov 4, 2026, before the open. After the last 4 reports the stock moved +11.4%, +-0.0%, −0.3%, −5.7% the next day.
CRL is expected to report on Wednesday, Nov 4, 2026, before the open (US Eastern time).
| Report | EPS est. | EPS | Next day | Week |
|---|---|---|---|---|
| Aug 5, 2026 | 2.74 | 3.02 | +11.4% | +20.5% |
| May 7, 2026 | 1.95 | 2.06 | +-0.0% | −10.4% |
| Feb 18, 2026 | 2.35 | 2.39 | −0.3% | +4.7% |
| Nov 5, 2025 | 2.34 | 2.43 | −5.7% | −2.4% |
| Aug 6, 2025 | 2.55 | 3.12 | −10.2% | −8.8% |
| May 7, 2025 | 2.07 | 2.34 | +18.7% | +24.8% |
| Feb 19, 2025 | 2.53 | 2.66 | +6.9% | +8.2% |
| Nov 6, 2024 | 2.42 | 2.59 | +13.5% | +14.4% |
Average move the next trading day over the last 8 reports: ±8.3% (4 of 8 up).
CRL is in an uptrend, momentum firm. $375 is the level overhead; $350 the first support below.
CRL at $351.87. Nearest resistance $375.00 (+6.6%). Nearest support $350.00 (−0.5%).
CRL chart, levels and analysis · Latest analysis: Charles River Laboratories (CRL) stock analysis, November 3, 2026: Uptrend intact as earnings near, price above consensus target · Earnings this week
CRL is expected to report on Wednesday, Nov 4, 2026, before the open.
CRL reports before the open, US Eastern time.
After its report on Aug 5, 2026, CRL moved +11.4% the next trading day.
Over the last 8 reports, CRL moved 8.3% on average the next trading day, up 4 times out of 8.